Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

spebrutinib MeSH Supplementary Concept Data 2025


MeSH Supplementary
spebrutinib
Unique ID
C583568
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C583568
Entry Term(s)
CC-292
N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide
Pharm Action
Protein Kinase Inhibitors
Registry Numbers
DRU6NG543J
Heading Mapped to
*Acrylamides
*Pyrimidines
Frequency
13
Note
inhibits Bruton's tyrosine kinase; structure in first source
Source
J Pharmacol Exp Ther. 2013 Aug;346(2):219-28.
Indexing Information
Protein Kinase Inhibitors
Date of Entry
2013/09/22
Revision Date
2019/09/19
spebrutinib Preferred
N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide Broader
CC-292 Narrower
page delivered in 0.005s